Related Experiment Video

Updated: Aug 18, 2026

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

Letter by Ran et al Regarding Article, "Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates

Qingzhi Ran1, Yongkang Zhang2, Hengwen Chen1

  • 1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China (Q.R., H.C.).

Circulation
|January 26, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice05:59

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice

Published on: May 14, 2020

A Murine Tail Lymphedema Model04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...